Correlation Between Sinphar Pharmaceutical and SciVision Biotech
Can any of the company-specific risk be diversified away by investing in both Sinphar Pharmaceutical and SciVision Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sinphar Pharmaceutical and SciVision Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Sinphar Pharmaceutical Co and SciVision Biotech, you can compare the effects of market volatilities on Sinphar Pharmaceutical and SciVision Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sinphar Pharmaceutical with a short position of SciVision Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sinphar Pharmaceutical and SciVision Biotech.
Diversification Opportunities for Sinphar Pharmaceutical and SciVision Biotech
0.79 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Sinphar and SciVision is 0.79. Overlapping area represents the amount of risk that can be diversified away by holding Sinphar Pharmaceutical Co and SciVision Biotech in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on SciVision Biotech and Sinphar Pharmaceutical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sinphar Pharmaceutical Co are associated (or correlated) with SciVision Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of SciVision Biotech has no effect on the direction of Sinphar Pharmaceutical i.e., Sinphar Pharmaceutical and SciVision Biotech go up and down completely randomly.
Pair Corralation between Sinphar Pharmaceutical and SciVision Biotech
Assuming the 90 days trading horizon Sinphar Pharmaceutical Co is expected to under-perform the SciVision Biotech. But the stock apears to be less risky and, when comparing its historical volatility, Sinphar Pharmaceutical Co is 1.89 times less risky than SciVision Biotech. The stock trades about -0.03 of its potential returns per unit of risk. The SciVision Biotech is currently generating about 0.04 of returns per unit of risk over similar time horizon. If you would invest 7,250 in SciVision Biotech on September 2, 2024 and sell it today you would earn a total of 1,920 from holding SciVision Biotech or generate 26.48% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 99.73% |
| Values | Daily Returns |
Sinphar Pharmaceutical Co vs. SciVision Biotech
Performance |
| Timeline |
| Sinphar Pharmaceutical |
| SciVision Biotech |
Sinphar Pharmaceutical and SciVision Biotech Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Sinphar Pharmaceutical and SciVision Biotech
The main advantage of trading using opposite Sinphar Pharmaceutical and SciVision Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sinphar Pharmaceutical position performs unexpectedly, SciVision Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in SciVision Biotech will offset losses from the drop in SciVision Biotech's long position.| Sinphar Pharmaceutical vs. Taiwan Semiconductor Manufacturing | Sinphar Pharmaceutical vs. Hon Hai Precision | Sinphar Pharmaceutical vs. MediaTek | Sinphar Pharmaceutical vs. Chunghwa Telecom Co |
| SciVision Biotech vs. Maxigen Biotech | SciVision Biotech vs. Chunghwa Chemical Synthesis | SciVision Biotech vs. Sinphar Pharmaceutical Co | SciVision Biotech vs. ScinoPharm Taiwan |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.
Other Complementary Tools
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum |